Overexpression of SREBP2 in the CNS results in an accumulation of cholesterol and neutral lipids and the emergence of ALS-like symptoms, including progressive hind limb paralysis, spasticity, and shortened lifespan in mice [120,133]. The gene discussed is SREBF2; the disease is amyotrophic lateral sclerosis.